Free forex prices, toplists, indices and lots more. The Estia Health Ltd (ASX: EHE) share price is tumbling lower today as the aged care provider officially gets cut from the S&P/ASX 200 Index. EHE Share Price - Get the latest Estia Health (EHE) share price ASX and detailed information including EHE Share Chart, EHE Share Technical Analysis and Financials / Fundamental Data. Movement. Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. Growing Profit Margin: EHE is currently unprofitable. Significantly Below Fair Value: EHE is trading below fair value by more than 20%. Estia Health Limited operates residential aged care homes in Australia. Unable to evaluate EHE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts. S&P does not guarantee the accuracy, adequacy, completeness or availability of any information and is not responsible for any errors or omissions, regardless of the cause or for the results obtained from the use of such information. How has Estia Health's share price performed over time and what events caused price changes? What is Estia Health's stock price today? In no event shall S&P be liable for any direct, indirect, special or consequential damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with subscriberâs or othersâ use of S&P Capital IQ. EHE's short term assets (A$50.6M) do not cover its. ASX:EHE Price Estimation Relative to Market, March 19th 2020. Health & Biotech. Mr. Thorley was the Chief Operating Officer of Esti... Show more. EHE is forecast to become profitable over the next 3 years, which is considered above average market growth. Revenue vs Market: EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). Debt Coverage: EHE's debt is well covered by operating cash flow (96.9%). Estia Health Ltd (EHE:ASX) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. have bought more shares than they have sold in the past 3 months. Aged care provider Estia Health Ltd suffered a weak start in today’s trading on the ASX. High Growth Revenue: EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. Is Estia Health undervalued compared to its fair value and its price relative to the market? ($USD585.53K) is about average for companies of similar size in the Australian market ($USD711.61K). EHE (A$1.71) is trading below our estimate of. The Clinuvel (ASX:CUV) share price edges down on Q1 update. 2. Growing Dividend: Insufficient data to determine if EHE's dividend payments have been increasing. Fair value with moderate growth potential. Long term investing works well, but it doesn't always work for each individual stock. Aged care operator Estia falls to loss as COVID-19 costs bite August 18, 2020 | Rachel Williamson. Is Estia Health (ASX:EHE) Using Too Much Debt? You must be a registered user to save alerts. Explore potentially undervalued companies in the Healthcare industry. Interest Coverage: EHE is unprofitable, therefore interest payments are not well covered by earnings. EHE is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-8.1%). EHE is forecast to become profitable over the next 3 years, which is considered faster growth than the. Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. Where can I find the current share price? 337927). Read detailed company information including current share prices, financial summary, directors, announcements, dividends & news. All else being equal, a share price drop should make a stock more attractive to potential investors. ASX Announcements and Latest News from ESTIA HEALTH LIMITED. It provides services across approximately 69 homes in New South Wales, Queensland, South. PEG Ratio: Insufficient data to calculate EHE's PEG Ratio to determine if it is good value. Experienced Management: EHE's management team is considered experienced (2.8 years average tenure). Formed in October 2013, Estia Health Limited (ASX:EHE) is one of the leading providers of residential aged care in Australia operating 6,182 resident places across 69 homes in New South Wales, Queensland, South Australia and Victoria. S&P DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. Estia Health Limited () Stock Market info Recommendations: Buy or sell Estia Health stock? What is Estia Health current dividend yield, its reliability and sustainability? How has Estia Health's share price performed over time and what events caused price changes? He joined Estia Health in October 2016. EHE's revenue (2.9% per year) is forecast to grow slower than 20% per year. It has 68 operational homes and 6,046 operational places for residents with over 7,000 employed staff. Insufficient data to determine if EHE's dividends per share have been stable in the past. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. According to a note out of Morgan Stanley, its analysts have downgraded this aged care operator’s shares to an underweight rating with a reduced price target of $1.50. At that level they are trading at 2.4% premium to the analyst consensus target price of 0.00. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree. Stable Share Price: EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. Explore strong past performing companies in the Healthcare industry. Join the HotCopper ASX share market forum today for free. EHE is trading below fair value by more than 20%. PE vs Industry: EHE is unprofitable, so we can't compare its PE Ratio to the AU Healthcare industry average. Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. ASX jumps on hope for COVID-19 drug remdesivir, ... Shares in Estia Health have dropped by 3.3 per cent to $1.45, ... driving up their share prices to record high levels. It provides services across approximately 69 homes in New South Wales, Queensland, South Australia and Victoria. Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Add this security to watchlist, portfolio, or create an alert to track market movement. Latest Share Price and Events Stable Share Price : EHE is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 9% a week. How experienced are the management team and are they aligned to shareholders interests? Earnings Trend: EHE is unprofitable, and losses have increased over the past 5 years at a rate of 13.5% per year. View the latest share news for ESTIA HEALTH and ASX:EHE RNS announcements, along with all the share chat by members of the Stockopedia community Volatility Over Time: EHE's weekly volatility (9%) has been stable over the past year. (-19.2%), as it is currently unprofitable. Mr. Thorley was the Chief Operating Officer of Esti. Mr. Ian Thorley is Chief Executive Officer and Managing Director at Estia Health Limited since November 23, 2018. Â© 2018 SIMPLY WALL STREET PTY LTD, COMMUNITY DESIGN 2845206, US DESIGN PATENT #29/544/281, EUROPEAN DESIGN REGISTRATION #2845206, STANDARD & POORâS FINANCIAL SERVICES LLC. Who are the major shareholders and have insiders been buying or selling? All rights reserved. Read More » All content on FT.com is for your general information and use only and is not intended to address your particular requirements. RELATED STOCKHEAD STORIES. Reducing Debt: EHE's debt to equity ratio has increased from 10% to 21.4% over the past 5 years. No risks detected for EHE from our risk checks. EHE's revenue (2.9% per year) is forecast to grow slower than the Australian market (5% per year). Unable to compare EHE's earnings growth over the past year to its 5-year average as it is currently unprofitable. $1.77. How is Estia Health's financial position? No need to calculate the sustainability of EHE's dividend in 3 years as they are not forecast to pay a notable one for the Australian market. Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. Reproduction of S&P Capital IQ in any form is prohibited except with the prior written permission of S&P. Tuesday 23 February 2021 commencing at 9.30am (AEDT) Estia Health Limited (ASX: EHE) (Estia or Company) advises that it will announce its FY21 Half Year results for the period ending 31 December 2020 on Tuesday 23 February 2021.Shareholders and guests will be able to pre-register by clicking here. EHE's is expected to become profitable in the next 3 years. Debt Level: EHE's debt to equity ratio (21.4%) is considered satisfactory.